Myeloma Minute: A Leap Forward for Myeloma Research

A Major Step Forward for the IMF's Black Swan Research Initiative®

The clear advantages of a powerful new myeloma diagnostic tool developed with IMF funding are underscored in a new study published this week. In his blog, IMF Chairman Dr. Brian Durie explains why Next Generation Flow is poised to push forward the Black Swan Research Initiative’s mission to achieve a cure. “The success of this key BSRI project beautifully illustrates the urgency for scientific rigor and fact—not only in attempting to cure myeloma, but also for keeping our planet and all of humanity safe and healthy,” he writes. To read Dr. Durie’s blog, click HERE.

Winter 2016/2017 Edition of Myeloma Today: ASH Highlights and More

The latest edition of Myeloma Today is out with a report on the most important take-aways from the myeloma-related presentations at the American Society of Hematology (ASH) meeting. Also included in this edition is a summary of the provocative pre-ASH, IMF program, “Treatment Advances in Multiple Myeloma: Translating Clinical Data to Practice” You’ll also read about the generous donors who helped fund 8 Brian D. Novis Research Grants. Enjoy the photo montage of our favorite stars from this year’s IMF’s 10th Annual Comedy Celebration. These stories and more are available HERE.

 

Tell Congress to Save Our Health Care

Sadly for many patients, the U.S. Congress has taken the first steps to repeal the Patient Protection and Affordable Care Act (ACA). The ACA has provided high-quality healthcare coverage to more than 22 million previously uninsured Americans. Many in the myeloma community and other vulnerable populations rely on the ACA for continued access to healthcare for themselves and their families. For cancer patients and survivors everywhere, please join us in telling Congress that any repeal must have a replacement that ensures no gaps in coverage for cancer patients and survivors.

 

Dr. Morie Gertz Reports on Improved Prognosis for Patients with Amyloidosis

In this video, Dr. Morie Gertz, a thirty-year amyloidosis researcher and the Chair of the Department of Internal Medicine at the Mayo Clinic-Rochester, discusses three important discoveries in the treatment of amyloidosis. Dr. Gertz discusses the new drugs NEOD001 (the PRONTO trial) and 11-F4, as well as the use of carfilzomib in patients with cardiac amyloid.

 

How You Can FUNdraise to Find a Cure

Thanks to our IMF community, 2016 was a banner year! Our members raised more than $700,000 through Member FUNdraisers to support research grants. These important grants were presented at the IMF Grant Reception at the ASH meeting this past December. How did so many people manage to do this? Bake sales, marathons, golf tournaments, you name it—so get involved! If you would like to launch your own FUNdraiser this year, contact Suzanne Battaglia.

 

 


We Would Like to Thank Our Sponsors: Takeda Oncology, Celgene, Amgen, and Bristol-Myers Squibb